TY - JOUR T1 - Pleurodesis outcome in malignant pleural mesothelioma JF - Thorax JO - Thorax SP - 594 LP - 596 DO - 10.1136/thoraxjnl-2012-203043 VL - 68 IS - 6 AU - Edward Thomas Hamilton Fysh AU - Sze Khen Tan AU - Catherine Ann Read AU - Felicity Lee AU - Kate McKenzie AU - Nola Olsen AU - Indunil Weerasena AU - Timothy Threlfall AU - Nicholas de Klerk AU - A William Musk AU - Y C Gary Lee Y1 - 2013/06/01 UR - http://thorax.bmj.com/content/68/6/594.abstract N2 - Few data exist on the pleurodesis outcome in patients with malignant pleural mesothelioma (MPM). A retrospective review of the Western Australian Mesothelioma Registry over 5 years revealed 390 evaluable patients. Only a subset of patients (42.3%) underwent pleurodesis, surgically (n=78) or by bedside instillation of sclerosants (n=87). Surgical pleurodesis showed no advantages over bedside pleurodesis in efficacy (32% vs 31% failures requiring further drainage, p=0.98), patient survival (p=0.52) or total time spent in hospital from procedure till death (p=0.36). No clinical, biochemical or radiographic parameters tested adequately predict pleurodesis outcome. ER -